Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence

Mayo Clin Proc. 2010 Oct;85(10):945-8. doi: 10.4065/mcp.2010.0520.

Authors

S Vincent Rajkumar¹, Robert A Kyle, Francis K Buadi

Affiliation

¹ Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. rajkumar.vincent@mayo.edu

No abstract available

Publication types

Review

MeSH terms

Cytological Techniques / methods
Diagnosis, Differential
Disease Progression
Global Health
Humans
Morbidity / trends
Paraproteinemias* / classification
Paraproteinemias* / diagnosis
Paraproteinemias* / epidemiology
Precancerous Conditions
Risk Assessment / methods*
Risk Factors
Survival Rate / trends